A novel Bcl-2/Bcl-XL inhibitor APG-1252-12A as a potential therapeutic strategy for gastric carcinoma

被引：0
|
作者：
Yan, Xianglei [1 ]
Yi, Hanjie [1 ]
Luo, Qiuyun [1 ]
Yuan, Luping [1 ]
Zhou, Suna [1 ]
Pan, Wentao [2 ]
Zhang, Lin [1 ]
Qiu, Miaozhen [1 ]
Yang, Dajun [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[2] Ascentage Pharma Inc, Suzhou, Peoples R China
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-2054
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2054
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor Toxicity
    Heisey, Daniel A. R.
    Lochmann, Timothy L.
    Floros, Konstantinos V.
    Coon, Colin M.
    Powell, Krista M.
    Jacob, Sheeba
    Calbert, Marissa L.
    Ghotra, Maninderjit S.
    Stein, Giovanna T.
    Maves, Yuki Kato
    Smith, Steven C.
    Benes, Cyril H.
    Leverson, Joel D.
    Souers, Andrew J.
    Boikos, Sosipatros A.
    Faber, Anthony C.
    CLINICAL CANCER RESEARCH, 2019, 25 (05) : 1664 - 1675
  • [42] Exploring the selectivity of inhibitor complexes with Bcl-2 and Bcl-XL: A molecular dynamics simulation approach
    Wakui, Naoki
    Yoshino, Ryunosuke
    Yasuo, Nobuaki
    Ohue, Masahito
    Sekijima, Masakazu
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2018, 79 : 166 - 174
  • [43] Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphoma
    Clare M. Adams
    Ramkrishna Mitra
    Ashley N. Vogel
    Jinglan Liu
    Jerald Z. Gong
    Christine M. Eischen
    Leukemia, 2020, 34 : 947 - 952
  • [44] Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphoma
    Adams, Clare M.
    Mitra, Ramkrishna
    Vogel, Ashley N.
    Liu, Jinglan
    Gong, Jerald Z.
    Eischen, Christine M.
    LEUKEMIA, 2020, 34 (03) : 947 - 952
  • [45] Mcl-1 levels critically impact the sensitivities of human colorectal cancer cells to APG-1252-M1, a novel Bcl-2/Bcl-XL dual inhibitor that induces Bax-dependent apoptosis
    Yao, Weilong
    Bai, Longchuan
    Wang, Shaomeng
    Zhai, Yifan
    Sun, Shi-Yong
    NEOPLASIA, 2022, 29
  • [46] Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer
    Y Loriot
    P Mordant
    D Dugue
    O Geneste
    A Gombos
    P Opolon
    J Guegan
    J-L Perfettini
    A Pierre
    L K Berthier
    G Kroemer
    J C Soria
    S Depil
    E Deutsch
    Cell Death & Disease, 2014, 5 : e1423 - e1423
  • [47] Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer
    Loriot, Y.
    Mordant, P.
    Dugue, D.
    Geneste, O.
    Gombos, A.
    Opolon, P.
    Guegan, J.
    Perfettini, J-L
    Pierre, A.
    Berthier, L. K.
    Kroemer, G.
    Soria, J. C.
    Depil, S.
    Deutsch, E.
    CELL DEATH & DISEASE, 2014, 5 : e1423 - e1423
  • [48] Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotides
    Bolenz, Christian
    Becker, Andreas
    Trojan, Lutz
    Schaaf, Axel
    Cao, Yanwei
    Weiss, Christel
    Alken, Peter
    Michel, Maurice Stephan
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2007, 25 (06) : 476 - 482
  • [49] Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells
    Chun, EY
    Lee, KY
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 315 (03) : 771 - 779
  • [50] Pyrazole and pyrimidine phenylacylsulfonamides as dual Bcl-2/Bcl-xL antagonists
    Schroeder, Gretchen M.
    Wei, Donna
    Banfi, Patrizia
    Cai, Zhen-Wei
    Lippy, Jonathan
    Menichincheri, Maria
    Modugno, Michele
    Naglich, Joseph
    Penhallow, Becky
    Perez, Heidi L.
    Sack, John
    Schmidt, Robert J.
    Tebben, Andrew
    Yan, Chunhong
    Zhang, Liping
    Galvani, Arturo
    Lombardo, Louis J.
    Borzilleri, Robert M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) : 3951 - 3956
12345